| Literature DB >> 35974937 |
Bita Rabbani1, Hossein Chiti1, Faranak Sharifi1, Saeedeh Mazloomzadeh1.
Abstract
Background: Lifestyle modifications, especially improving nutritional patterns and increasing physical activity are the most important factors in preventing obesity and metabolic syndrome in children and adolescents. For this purpose, the following interventional study was designed to investigate the effects of educational programs for students, as well as the changes in diet and physical activity on obesity and components of the metabolic syndrome.Entities:
Keywords: Hypertension; Life style; Metabolic syndrome; Nutrition; Obesity
Year: 2022 PMID: 35974937 PMCID: PMC9348219 DOI: 10.22088/cjim.13.3.555
Source DB: PubMed Journal: Caspian J Intern Med ISSN: 2008-6164
Comparison of anthropometric indices, nutrition and physical activities of primary school students between intervention and control groups at the beginning of the study and in two years*
|
|
|
| ||
|---|---|---|---|---|
|
|
| |||
| Height – cm | Beginning of study | 126.0±12.6 | 134.6±10.9 | <0.001 |
| End of second year | 134.2±10.4 | 143.0±10.9 | <0.001 | |
| Weight - kg | Beginning of study | 29.9±9.2 | 31.5±9.5 | 0.002 |
| End of second year | 32.3±10.3 | 36.2±11.2 | <0.001 | |
| BMI - kg/m2 | Beginning of study | 18.6±3.5 | 17.1±3.2 | <0.001 |
| End of second year | 17.6±3.7 | 17.4±3.6 | 0.229 | |
| Abdominal circumference – cm | Beginning of study | 61.2±9.5 | 61.6±9.5 | 0.32 |
| End of second year | 63.8±10.9 | 66.8±10.4 | <0.001 | |
| Systolic blood pressure - mmHg | Beginning of study | 103.1±12.6 | 95.3±10.2 | <0.001 |
| End of second year | 101.0±12.5 | 98.6±6.5 | <0.001 | |
| Diastolic blood pressure - mmHg | Beginning of study | 65.6±12.1 | 62.4±4.4 | <0.001 |
| End of second year | 64.9±10.4 | 66.4±5.9 | 0.001 | |
| Food habit points | Beginning of study | 23.2±4.9 | 24.2±4.9 | 0.002 |
| End of second year | 25.0±5.0 | 23.9±5.4 | 0.001 | |
| Healthy drinking points | Beginning of study | 12.02±2.5 | 11.4±2.3 | <0.001 |
| End of second year | 12.1±2.3 | 10.9±2.5 | <0.001 | |
| Inactivity points (TSS) | Beginning of study | 2.91±1.6 | 3.3±1.7 | <0.001 |
| End of second year | 3.2±1.7 | 3.5±2.0 | 0.155 | |
| Physical activity points (TAS) | Beginning of study | 5.8±2.6 | 6.5±2.4 | <0.001 |
| End of second year | 6.7± 2.6 | 7.1±3.2 | 0.176 | |
BMI: Body mass index; TSS: Training Stress Score; TAS: Tegner Activity Scale *All plus-minus values are means and standard deviations.
Comparison of metabolic syndrome components between intervention and control groups at the beginning of the study.*
|
|
|
| ||
|---|---|---|---|---|
|
|
| |||
| Both | 13 (6.5) | 1 (1.4) | 0.105 | |
| Abdominal obesity – no. (%) | Males | 11 (4.5) | 12 (4.9) | 0.870 |
| Girls | 21 (6.1) | 15 (4.4) | 0.296 | |
| Both | 34 (5.8) | 27 (4.6) | 0.330 | |
| Overweight – no. (%) | Males | 55 (22.8) | 35 (14.1) | <0.001 |
| Females | 60 (17.6) | 46 (13.4) | <0.001 | |
| Both | 115 (19.7) | 81 (13.7) | <0.001 | |
| Obesity – no. (%) | Males | 101 (41.9) | 39 (15.7) | <0.001 |
| Females | 55 (16.1) | 25 (7.3) | <0.001 | |
| Both | 158 (27.1) | 64 (10.8) | <0.001 | |
| High blood pressure – no. (%) | Males | 155 (64.3) | 216 (87.4) | <0.001 |
| Females | 286 (84.4) | 224 (65.5) | <0.001 | |
| Both | 443 (76.4) | 440 (74.7) | 0.505 | |
| High systolic blood pressure – no. (%) | Males | 101 (41.9) | 105 (42.5) | 0.893 |
| Females | 238 (70.2) | 77 (22.5) | <0.001 | |
| Both | 340 (58.5) | 182 (30.9) | <0.001 | |
| High diastolic blood pressure – no. (%) | Males | 137 (56.8) | 211 (85.8) | <0.001 |
| Females | 272 (80.2) | 214 (62.6) | <0.001 | |
| Both | 411 (70.7) | 425 (72.3) | 0.592 | |
| Hypertriglyceridemia– no. (%) | Males | 5 (5.5) | 1 (3.3) | 0.0636 |
| Females | 8 (6.7) | 1 (2.3) | 0.269 | |
| Both | 13 (6.2) | 2 (2.7) | 0.249 | |
| LDL ≥ 110mg/dL – no. (%) | Males | 15 (16.5) | 0 (0) | 0.018 |
| Females | 19 (16.0) | 12 (27.3) | 0.102 | |
| Both | 34 (16.2) | 12 (16.2) | 0.996 | |
| Low HDL– no. (%) | Males | 28 (30.8) | 8 (26.7) | 0.670 |
| Females | 41 (34.5) | 11 (25.0) | 0.250 | |
| Both | 69 (32.9) | 19 (25.7) | 0.251 | |
| Hyperglycemia (>100mg/dL) – no. (%) | Males | 2 (1.5) | 0 (0) | 0.502 |
| Females | 6 (5.0) | 0 (0) | 0.129 | |
| Both | 8 (3.1) | 0 (0) | 0.122 | |
| Insulin resistance – no. (%)† | Males | 16 (17) | 2 (7.4) | 0.216 |
| Females | 42 (35.6) | 3 (6.8) | <0.001 | |
| Both | 58 (27.4) | 5 (7.0) | <0.001 | |
| Metabolic syndrome – no. (%) | Males | 4 (4.1) | 0 (0) | 0.269 |
| Females | 9 (7.7) | 1 (2.3) | 0.204 | |
*Components of metabolic syndrome are defined according to the Program’s Adult Treatment Panel (ATP) III criteria as TG ≥ 150mg/dl, HDL-c < 40mg/dl, systolic blood pressure > 130mmHg or diastolic blood pressure > 85mmHg and FBS > 100mg/dl. †Insulin resistance was defined as insulin resistance index (HOMA-IR) greater than 1/2.
Comparison of frequency distribution of metabolic syndrome components between intervention and control groups among elementary students at end of the second year.*
|
|
|
| ||
|---|---|---|---|---|
|
|
| |||
| Abdominal obesity – no. (%) | Males | 5 (2.2) | 10 (4.4) | 0.189 |
| Females | 8 (2.9) | 9 (2.8) | 0.907 | |
| Both | 13 (2.6) | 19 (3.4) | 0.400 | |
| Overweight – no. (%) | Males | 13 (5.8) | 35 (5.8) | 0.029 |
| Females | 20 (7.2) | 15 (4.6) | 0.194 | |
| Both | 39 (7.8) | 52 (9.4) | 0.400 | |
| Obesity – no. (%) | Males | 12 (5.3) | 28 (12.4) | |
| Females | 27 (9.8) | 24 (7.4) | ||
| Both | 33 (6.6) | 28 (5.1) | ||
| High blood pressure – no. (%) | Males | 79 (35.0) | 150 (66.4) | <0.001 |
| Females | 133 (48.4) | 231 (71.7) | <0.001 | |
| Both | 212 (43.3) | 381 (69.5) | <0.001 | |
| High systolic blood pressure – no. (%) | Males | 38 (16.8) | 34 (15.0) | 0.607 |
| Females | 84 (30.5) | 53 (16.5) | <0.001 | |
| Both | 122 (24.4) | 87 (15.9) | 0.001 | |
| High diastolic blood pressure – no. (%) | Males | 76 (33.6) | 150 (66.4) | <0.001 |
| Females | 116 (42.2) | 231 (71.7) | <0.001 | |
| Both | 192 (38.3) | 381 (69.5) | <0.001 | |
| Hypertriglyceridemia – no. (%) | Males | 14 (21.9) | 2 (8.3) | 0.142 |
| Females | 29 (36.2) | 1 (2.3) | 0.269 | |
| Both | 43 (29.9) | 6 (13) | 0.020 | |
| LDL >=110 mg/dL – no. (%) | Males | 17 (26.6) | 4 (16.7) | 0.332 |
| Females | 34 (42.5) | 8 (36.4) | 0.605 | |
| Both | 51 (35.4) | 12 (26.1) | 0.240 | |
| HDL– no. (%) | Males | 21 (32.8) | 3 (12.5) | 0.057 |
| Females | 15 (18.8) | 7 (31.8) | 0.187 | |
| Both | 36 (25) | 10 (21.7) | 0.650 | |
| Hyperglycemia– no. (%) | Males | 1 (1.6) | 0 (0) | 0.538 |
| Females | 0 (0) | 0 (0) | 1.000 | |
| Both | 1 (7.0) | 0 (0) | 0.570 | |
| Insulin resistance – no. (%) | Males | 6 (9.5) | 5 (20.8) | 0.156 |
| Females | 35 (45.5) | 3 (13.6) | 0.007 | |
| Both | 41 (29.3) | 8 (17.4) | 0.112 | |
| Metabolic syndrome – no. (%) | Males | 10 (23.3) | 0 (0) | 0.049 |
| Females | 4 (7.3) | 2 (15.4) | 0.354 | |
| Both | 14 (143) | 2 (6.9) | 0.300 | |
*Components of metabolic syndrome are defined according to the Program’s Adult Treatment Panel (ATP) III criteria as TG ≥ 150mg/dl, HDL-c < 40mg/dl, systolic blood pressure > 130mmHg or diastolic blood pressure > 85mmHg and FBS > 100mg/dl. †Insulin resistance was defined as insulin resistance index (HOMA-IR) greater than 1/2.
Comparison of frequency distribution of metabolic syndrome components between intervention and control groups among elementary students at beginning of the study and end of the second year
|
|
|
| ||
|---|---|---|---|---|
|
|
| |||
| Abdominal obesity – no. (%) | Intervention | 34 (5.8) | 7 (1.2) | <0.001 |
| control | 15(4.8) | 15 (4.8) | 1.000 | |
| Overweight – no. (%) | Intervention | 4 (0.7) | 42 (4.1) | <0.001 |
| control | 34 (10.9) | 24 (7.7) | ||
| Obesity – no. (%) | Intervention | 11 (1.9) | 16 (2.7) | 0.173 |
| control | 39 (12.5) | 43 (13.8) | ||
| High blood pressure – no. (%) | Intervention | 443 (76.4) | 130 (22.4) | <0.001 |
| control | 221 (72.2) | 290 (94.8) | <0.001 | |
| High systolic blood pressure – no. (%) | Intervention | 340 (58.5) | 98 (16.9) | <0.001 |
| control | 91 (29.7) | 68 (22.2) | 0.033 | |
| High diastolic blood pressure – no. (%) | Intervention | 422 (70.7) | 128 (22.0) | <0.001 |
| control | 213 (69.6) | 290 (94.8) | <0.001 | |
| Hypertriglyceridemia– no. (%) | Intervention | 6 (5.1) | 37 (31.6) | <0.001 |
| control | 2 (5.9) | 6 (17.6) | 0.219 | |
| LDL >=110 mg/dL – no. (%) | Intervention | 17 (14.5) | 39 (33.3) | <0.001 |
| control | 4 (11.8) | 7 (20.6) | 0.453 | |
| HDL– no. (%) | Intervention | 38 (32.5) | 30 (25.6) | 0.215 |
| control | 8 (23.5) | 9 (26.5) | 1.000 | |
| Hyperglycemia – no. (%) | Intervention | 4 (3.3) | 1 (0.8) | 0.375 |
| control | - | - | - | |
| Insulin resistance – no. (%) | Intervention | 58 (27.4) | 6 (9.5) | <0.001 |
| control | 2 (6.1) | 6 (18.2) | 0.219 | |
| Metabolic syndrome – no. (%) | Intervention | 7 (8.6) | 13 (16) | 0.180 |
| control | 1 (4.8) | 2 (9.5) | 1.000 | |
*Components of metabolic syndrome are defined according to the Program’s Adult Treatment Panel (ATP) III criteria as TG ≥ 150mg/dl, HDL-c < 40mg/dl, systolic blood pressure > 130mmHg or diastolic blood pressure > 85mmHg and FBS > 100mg/dl. †Insulin resistance was defined as insulin resistance index (HOMA-IR) greater than 2.1.